vTv Therapeutics Inc (VTVT)
29.38
+0.26
(+0.89%)
USD |
NASDAQ |
May 02, 13:46
vTv Therapeutics Max Drawdown (5Y): 94.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 94.98% |
March 31, 2024 | 94.98% |
February 29, 2024 | 94.98% |
January 31, 2024 | 94.98% |
December 31, 2023 | 94.98% |
November 30, 2023 | 94.98% |
October 31, 2023 | 94.98% |
September 30, 2023 | 94.98% |
August 31, 2023 | 94.98% |
July 31, 2023 | 94.98% |
June 30, 2023 | 94.98% |
May 31, 2023 | 94.98% |
April 30, 2023 | 94.98% |
March 31, 2023 | 94.98% |
February 28, 2023 | 94.98% |
January 31, 2023 | 94.98% |
December 31, 2022 | 94.98% |
November 30, 2022 | 94.98% |
October 31, 2022 | 94.98% |
September 30, 2022 | 94.98% |
August 31, 2022 | 94.98% |
July 31, 2022 | 94.98% |
June 30, 2022 | 94.98% |
May 31, 2022 | 94.98% |
April 30, 2022 | 93.57% |
Date | Value |
---|---|
March 31, 2022 | 93.57% |
February 28, 2022 | 93.57% |
January 31, 2022 | 93.57% |
December 31, 2021 | 93.57% |
November 30, 2021 | 93.57% |
October 31, 2021 | 93.57% |
September 30, 2021 | 93.57% |
August 31, 2021 | 93.57% |
July 31, 2021 | 93.57% |
June 30, 2021 | 93.57% |
May 31, 2021 | 93.57% |
April 30, 2021 | 93.57% |
March 31, 2021 | 93.57% |
February 28, 2021 | 93.57% |
January 31, 2021 | 93.57% |
December 31, 2020 | 93.57% |
November 30, 2020 | 93.57% |
October 31, 2020 | 93.57% |
September 30, 2020 | 93.57% |
August 31, 2020 | 93.57% |
July 31, 2020 | 93.57% |
June 30, 2020 | 93.57% |
May 31, 2020 | 93.57% |
April 30, 2020 | 93.57% |
March 31, 2020 | 93.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.57%
Minimum
May 2019
94.98%
Maximum
May 2022
94.13%
Average
93.57%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Altimmune Inc | 99.85% |
Palatin Technologies Inc | 96.46% |
Oragenics Inc | 98.92% |
Viking Therapeutics Inc | 89.26% |
G1 Therapeutics Inc | 97.24% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -22.06 |
Beta (5Y) | 0.5213 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.34% |
Historical Sharpe Ratio (5Y) | -0.1687 |
Historical Sortino (5Y) | -0.4376 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.80% |